Cargando…
URI regulates tumorigenicity and chemotherapeutic resistance of multiple myeloma by modulating IL-6 transcription
Unconventional prefoldin RPB5 interactor (URI), which acts as an oncoprotein in solid tumors, is associated with RNA polymerase II subunit 5. However, its impact on multiple myeloma (MM) has not been determined. We demonstrate here that URI is overexpressed in MM compared with plasma cells derived f...
Autores principales: | Fan, J-L, Zhang, J, Dong, L-W, Fu, W-J, Du, J, Shi, H-G, Jiang, H, Ye, F, Xi, H, Zhang, C-Y, Hou, J, Wang, H-Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973192/ https://www.ncbi.nlm.nih.gov/pubmed/24625985 http://dx.doi.org/10.1038/cddis.2014.93 |
Ejemplares similares
-
Dr. Uri Colvin Lynde
Publicado: (1916) -
The yeast prefoldin-like URI-orthologue Bud27 associates with the RSC nucleosome remodeler and modulates transcription
por: Mirón-García, María Carmen, et al.
Publicado: (2014) -
The iron deficiency response in Arabidopsis thaliana requires the phosphorylated transcription factor URI
por: Kim, Sun A., et al.
Publicado: (2019) -
A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse.
por: Manning, L. S., et al.
Publicado: (1992) -
Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study
por: Logallo, Nicola, et al.
Publicado: (2011)